Pfizer Inc (PFE)

48.680
+0.540(+1.12%)
  • Volume:
    1
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    48.160 - 48.680

PFE Overview

Prev. Close
48.14
Day's Range
48.16-48.68
Revenue
99.88B
Open
48.16
52 wk Range
40.455-54.33
EPS
5.31
Volume
1
Market Cap
271.11B
Dividend (Yield)
1.60
(3.12%)
Average Volume (3m)
191
P/E Ratio
9.75
Beta
0.642
1-Year Change
2.45%
Shares Outstanding
5,613,314,537
Next Earnings Date
-
What is your sentiment on Pfizer?
or
Vote to see community's results!

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Austria
  • ISIN:US7170811035

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Analyst Price Target

Average54.900 (+7.84% Upside)
High75
Low44
Price50.91
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong Buy